12,851 resources
Start Prev Rows 7600 - 7800 Next
Package | Version | Identity | Name/Title | Status | FMM | WG | Date | Auth | Source(s) |
---|---|---|---|---|---|---|---|---|---|
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1219.134 | Sleep Related Symptom for Positive Airway Pressure Device Use Evaluation | active | 2022-03 | hl7 | sct | ||
us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.7753 | Directionality of Link (TB) | active | 2017-12 | sct | |||
signal.core.r4 | R4 | questionnaire-ccars-disabilities | Questionnaire CCARS Disabilities | draft | 1 | pa | hl7 | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1099.49 | Disability Status Assessment | active | 2024-08 | hl7 | loinc | ||
hl7.fhir.us.military-service | R4 | military-service-discharge-status-vs | Discharge Status Value Set | active | 2023-05 | hl7 | fhir | ||
us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.909 | Disease | active | 2019-12 | sct | |||
us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.7970 | Disease Stage (Brucellosis) | active | 2021-01 | sct tho | |||
fhir.org.nz.ig.base | R4 | dhb | District Health Board Identifer | active | 2025-06 | hl7 | |||
hl7.fhir.us.spl | R5 | splDocumentCodes | SPL Document Codes | trial-use | 1 | brr | 2025-07 | hl7 | loinc |
signal.core.r4 | R4 | signal-filerepo-docreviewstatus | Signal FileRepo DocStatus | draft | 2023-09 | hl7 | |||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1222.672 | Entrapment Neuropathy | active | 2024-07 | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.1444.5.228 | Low Emetic Risk Intravenous Antineoplastic Agent | active | 2025-04 | hl7 | vsac | ||
us.nlm.vsac | R4 | 1.3.6.1.4.1.6997.4.1.2.271.12.37696.1.1.999.654 | Proton Pump Inhibitors not including for H. pylori treatment | active | 2019-04 | hl7 | rx | ||
fhir.org.nz.ig.base | R4 | domicile-code | Domicile Code | active | 2025-06 | hl7 | |||
us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.7927 | Dose Unit (STD) | active | 2020-01 | ucum sct tho | |||
us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.7630 | Drinking Water (FDD) | active | 2017-01 | tho oid | |||
us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.1071 | Drug Susceptibility Test Result Name | active | 2008-01 | loinc | |||
us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.1102 | Drug Active Ingredients | active | 2008-01 | oid | |||
us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.1108 | Drug Classes (NDF-RT) | active | 2008-01 | tho | |||
us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.1106 | Drug Manufacturers (NDC) | active | 2008-01 | ndc | |||
us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.7467 | Drug Disease Interaction (Dengue) | active | 2016-01 | sct | |||
us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.7055 | Antituberculosis Drugs (TB) | active | 2013-01 | rx | |||
hl7.fhir.us.breast-radiology | R4 | DuctAbnormalityTypeVS | Duct Abnormality Type ValueSet | active | 2022-12 | hl7 | fhir | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.1.11.14914 | Race Value Set | active | 2024-06 | hl7 | oid | ||
us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.7926 | Number of Cigarettes Smoked per Day (CO) | active | 2019-01 | sct tho oid | |||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.292 | Metabolic syndrome I10 | active | 2023-09 | hl7 | icd | ||
hl7.fhir.us.registry-protocols | R4 | STEMIFirstNoted | STEMI or STEMI Equivalent First Noted | active | cic | 2023-11 | hl7 | fhir | |
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1260.232 | EGFR Molecular Variants Amivantamab PM | active | 2024-05 | hl7 | loinc | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1260.231 | EGFR Amivantamab Molecular Variants | active | 2024-05 | hl7 | loinc | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1260.56 | Early and Limited Stage | active | 2023-11 | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1260.57 | Early Stage IIB or lower | active | 2023-11 | hl7 | ncit | ||
hl7.fhir.us.registry-protocols | R4 | ElectrocardiacAbnormalityType | Electrocardiac Abnormality Type | active | cic | 2023-11 | hl7 | fhir sct | |
hl7.fhir.us.registry-protocols | R4 | ElectrocardiacAssessmentMethod | Electrocardiac Assessment Method | active | cic | 2023-11 | hl7 | fhir sct | |
hl7.fhir.us.registry-protocols | R4 | ElectrocardiacAssessmentResults | Electrocardiac Assessment Results | active | cic | 2023-11 | hl7 | fhir sct | |
us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.985 | Employment Status | active | 2008-01 | sct tho | |||
us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.1011 | Data Subtype | active | 2008-01 | ||||
us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.1012 | Type of Data | active | 2008-01 | ||||
ca.on.dhdr.r4.v4 | R4 | encounter-class | Encounter Class | active | hl7 | tho | |||
fhir.cdc.opioid-cds-r4 | R4 | condition-encounter-diagnosis-category | Encounter Diagnosis Condition Category | active | 2023-05 | hl7 | |||
hl7.fhir.us.directory-query | R4 | EndpointConnectionTypeVS | Endpoint Connection Types Value Set | active | 2022-12 | hl7 | fhir tho | ||
hl7.fhir.us.davinci-pdex-plan-net | R4 | EndpointConnectionTypeVS | Endpoint Connection Types VS | trial-use | fm | 2025-02 | hl7 | fhir tho | |
hl7.fhir.us.ndh | R4 | EndpointConnectionTypeVS | Endpoint Connection Types Value Set | trial-use | pa | 2025-07 | hl7 | fhir ihe tho | |
hl7.fhir.us.ndh | R4 | EndpointFhirMimeTypeVS | Endpoint FHIR Mimetype Value Set | trial-use | pa | 2025-07 | hl7 | ietf | |
hl7.fhir.us.ndh | R4 | EndpointIheSpecificConnectionTypeVS | Endpoint IHE Specific Connection Types Value Set | trial-use | pa | 2025-07 | hl7 | ihe | |
hl7.fhir.us.directory-query | R4 | EndpointPayloadTypeVS | Endpoint Payload Type Value Set | active | 2022-12 | hl7 | fhir | ||
hl7.fhir.us.davinci-pdex | R4 | EndpointPayloadTypeVS | Endpoint Payload Type Value Set | trial-use | 2 | fm | 2025-06 | hl7 | fhir |
hl7.fhir.us.davinci-pdex-plan-net | R4 | EndpointPayloadTypeVS | Endpoint Payload Types VS | trial-use | fm | 2025-02 | hl7 | fhir | |
hl7.fhir.us.ndh | R4 | EndpointPayloadTypeVS | Endpoint Payload Type Value Set | trial-use | pa | 2025-07 | hl7 | tho | |
signal.core.r4 | R4 | questionnaire-ccars-enrollment-payer | Questionnaire CCARS Enrollment Payer | draft | 1 | pa | hl7 | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1095.58 | Nutrition Order Item Grouping | active | 2018-04 | hl7 | vsac | ||
us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.3129 | Injury Occurred Environment (VPD) | active | 2008-01 | sct tho oid | |||
us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.7674 | Lab Test Interpretation (Trich) | active | 2018-01 | sct tho | |||
us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.7744 | Lab Test Interpretation (TB) | active | 2019-01 | sct tho oid | |||
us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.7734 | Lab Test Interpretation (RIBD) | active | 2018-01 | sct tho oid | |||
us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.7867 | Test Result (C. auris) | active | 2019-01 | sct | |||
us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.3252 | Lab Test Interpretation (Flu) | active | 2009-01 | sct oid | |||
us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.7823 | Lab Test Interpretation (Legionellosis) | active | 2018-01 | sct tho oid | |||
us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.7334 | Lab Test Interpretation (Pertussis) | active | 2016-01 | sct tho oid | |||
us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.3301 | Lab Test Interpretation (VPD) | active | 2022-01 | sct tho oid | |||
us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.3263 | Lab Test Interpretation (Pediatric Flu) | active | 2009-01 | sct oid | |||
us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.3251 | Lab Test Procedure (Flu) | active | 2009-01 | sct | |||
us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.3309 | Lab Test Procedure (Malaria) | active | 2016-01 | oid loinc | |||
us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.3302 | Lab Test Procedure (Measles) | active | 2010-01 | sct tho oid | |||
us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.3306 | Lab Test Procedure (Mumps) | active | 2010-01 | sct tho oid | |||
us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.7545 | Lab Test Type (Babesiosis) | active | 2017-01 | oid loinc | |||
us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.3262 | Lab Test Procedure (Pediatric Flu) | active | 2009-01 | sct oid | |||
us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.7673 | Lab Test Type (Trich) | active | 2018-01 | oid | |||
us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.7775 | Lab Test Type (RIBD) | active | 2019-01 | oid | |||
us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.7835 | Lab Test Type (TBRD) | active | 2022-01 | oid loinc | |||
us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.7863 | Lab Test Type (C. auris) | active | 2018-01 | oid | |||
us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.7743 | Lab Test Type (TB) | active | 2018-01 | oid loinc | |||
us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.7948 | Lab Test Type (COVID-19) | active | 2021-01 | oid loinc | |||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1146.227 | Lyme Disease (Disorders) (ICD10CM) | active | 2023-01 | hl7 | icd | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1146.226 | Lyme Disease (Disorders) (SNOMED) | active | 2025-02 | hl7 | sct | ||
us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.3015 | Ethnicity Group including Unknown | active | 2008-01 | tho oid | |||
fhir.org.nz.ig.base | R4 | ethnicityfull | Ethnicity of a person (full) | active | 2025-06 | hl7 | |||
us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.3359 | Evaluation Finding | active | 2010-01 | sct | |||
us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.1068 | Event | active | 2010-01 | sct | |||
hl7.fhir.us.birthdefectreporting | R4 | bdr-eventtypes | Birth Defect Report Event Types | active | pher | 2025-06 | hl7 | loinc | |
fhir.ops-esavi | R4 | NombreESAVIVS | Código nombre ESAVI | active | 2021-03 | hl7 | internal | ||
us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.3293 | Evidence Of Immunity (IIS) | active | 2010-01 | sct | |||
signal.core.r4 | R4 | device-action | Procedure Device Action Codes | draft | pc | 2019-10 | hl7 | sct | |
hl7.fhir.us.military-service | R4 | military-service-combat-episode-mission-vs | Combat Episode Mission Value Set | active | 2023-05 | hl7 | fhir | ||
hl7.fhir.us.davinci-vbpr | R4 | measure-stratifier-example | Measure Stratifier Example | trial-use | 1 | cqi | 2025-07 | hl7 | fhir |
hl7.fhir.us.pco | R4 | what-matters-codes-example | What Matters Codes Example | draft | 2 | pc | 2025-03 | hl7 | fhir sct |
hl7.fhir.us.pco | R4 | pco-goal-barrier-types-example-vs | Goal Barrier Types Example | draft | 2 | pc | 2025-03 | hl7 | sct |
hl7.fhir.us.pco | R4 | wellbeing-domains-example | Well-Being Domains Example | draft | 2 | pc | 2025-03 | hl7 | fhir |
hl7.fhir.us.davinci-crd | R4 | serviceRequestCodes | CRD Service Request Codes Value Set | trial-use | 3 | fm | 2025-07 | hl7 | sct cpt cms loinc |
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.680 | GLP1RA DM ASCVD | active | 2024-02 | hl7 | rx | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.3157.2000.5 | Percutaneous Coronary Intervention | active | 2022-03 | hl7 | vsac | ||
hl7.fhir.us.registry-protocols | R4 | ValvularRegurgitation | Valvular Regurgitation | active | cic | 2023-11 | hl7 | sct | |
us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.7369 | Present on Admission (NCHS) | active | 2015-01 | sct tho | |||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1032.296 | SCT Findings 202209 | active | 2024-03 | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1032.309 | SCT Findings 202309 | active | 2024-03 | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1032.311 | SCT Procedures 202209 | active | 2024-03 | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1032.312 | SCT Procedures 202309 | active | 2024-03 | hl7 | sct | ||
us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.8017 | Exposure Source (Brucellosis) | active | 2021-01 | sct tho oid | |||
us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.7198 | Transmission Category (STD) | active | 2020-01 | oid | |||
us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.7978 | Exposure Risk (Brucellosis) | active | 2020-01 | sct tho | |||
us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.7942 | Exposure Setting (COVID-19) | active | 2020-01 | sct tho oid | |||
us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.7994 | Exposure Type (Leptospirosis) | active | 2020-01 | tho oid | |||
us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.1024 | Extended Priority Codes (HL7) | active | 2008-01 | tho | |||
hl7.fhir.us.davinci-crd | R4 | CMSMappableLocationCodes | CMS Mappable Location Codes | trial-use | 1 | fm | 2025-07 | hl7 | fhir tho |
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1178.97 | AHA GWTG Long COVID19 SNOMEDCT | active | 2024-10 | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1178.98 | AHA GWTG Long COVID19 ICD10CM | active | 2024-10 | hl7 | icd | ||
signal.core.r4 | R4 | questionnaire-ccars-aggression-danger-to-others-rating | Questionnaire CCARS Aggression Danger To Others Rating | draft | 1 | pa | hl7 | ||
signal.core.r4 | R4 | questionnaire-ccars-role-performance-rating | Questionnaire CCARS Role Performance Rating | draft | 1 | pa | hl7 | ||
signal.core.r4 | R4 | questionnaire-ccars-interpersonal-rating | Questionnaire CCARS Interpersonal Rating | draft | 1 | pa | hl7 | ||
signal.core.r4 | R4 | questionnaire-ccars-multiple-issues-rating | Questionnaire CCARS Multiple Issues Rating | draft | 1 | pa | hl7 | ||
signal.core.r4 | R4 | questionnaire-ccars-psychosis-rating | Questionnaire CCARS Psychosis Rating | draft | 1 | pa | hl7 | ||
signal.core.r4 | R4 | questionnaire-ccars-depressive-issues-rating | Questionnaire CCARS Depressive Issues Rating | draft | 1 | pa | hl7 | ||
signal.core.r4 | R4 | questionnaire-ccars-suicide-danger-to-self-rating | Questionnaire CCARS Suicide Danger To Others Rating | draft | 1 | pa | hl7 | ||
signal.core.r4 | R4 | questionnaire-ccars-social-support-rating | Questionnaire CCARS Social Support Rating | draft | 1 | pa | hl7 | ||
signal.core.r4 | R4 | questionnaire-ccars-overall-level-of-functioning-rating | Questionnaire CCARS Overall Level Of Functioning Rating | draft | 1 | pa | hl7 | ||
signal.core.r4 | R4 | questionnaire-ccars-legal-rating | Questionnaire CCARS Legal Rating | draft | 1 | pa | hl7 | ||
signal.core.r4 | R4 | questionnaire-ccars-overall-recovery-rating | Questionnaire CCARS Overall Recovery Rating | draft | 1 | pa | hl7 | ||
signal.core.r4 | R4 | questionnaire-ccars-hope-rating | Questionnaire CCARS Hope Rating | draft | 1 | pa | hl7 | ||
signal.core.r4 | R4 | questionnaire-ccars-activity-involvement-rating | Questionnaire CCARS Overall Activity Involvement Rating | draft | 1 | pa | hl7 | ||
signal.core.r4 | R4 | questionnaire-ccars-cognition-rating | Questionnaire CCARS Cognition Rating | draft | 1 | pa | hl7 | ||
signal.core.r4 | R4 | questionnaire-ccars-empowerment-rating | Questionnaire CCARS Empowerment Rating | draft | 1 | pa | hl7 | ||
signal.core.r4 | R4 | questionnaire-ccars-socialization-rating | Questionnaire CCARS Socialization Rating | draft | 1 | pa | hl7 | ||
signal.core.r4 | R4 | questionnaire-ccars-physical-health-rating | Questionnaire CCARS Physical Health Rating | draft | 1 | pa | hl7 | ||
signal.core.r4 | R4 | questionnaire-ccars-alcohol-use-rating | Questionnaire CCARS Alcohol Use Rating | draft | 1 | pa | hl7 | ||
signal.core.r4 | R4 | questionnaire-ccars-drug-use-rating | Questionnaire CCARS Drug Use Rating | draft | 1 | pa | hl7 | ||
signal.core.r4 | R4 | questionnaire-ccars-family-rating | Questionnaire CCARS Family Rating | draft | 1 | pa | hl7 | ||
signal.core.r4 | R4 | questionnaire-ccars-self-care-basic-needs-rating | Questionnaire CCARS Self Care Basic Needs Rating | draft | 1 | pa | hl7 | ||
signal.core.r4 | R4 | questionnaire-ccars-security-supervision-rating | Questionnaire CCARS Security Supervision Rating | draft | 1 | pa | hl7 | ||
us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.7621 | Signs and Symptoms (FDD) | active | 2017-01 | sct tho | |||
signal.core.r4 | R4 | v2-2.7-0360 | v2 table 0360, Version 2.7 | draft | 1 | pa | hl7 | tho | |
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.113.11.1094 | Ehlers Danlos Syndrome | active | 2018-03 | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.113.12.1047 | Ehlers Danlos Syndrome | active | 2024-01 | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1206.41 | TricyclicAntidepressants | active | 2021-07 | hl7 | rx | ||
us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.1056 | Vaccination Location (CRA) | active | 2008-01 | sct tho oid | |||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1206.35 | Assymetry Symptoms | active | 2021-07 | hl7 | icd | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1206.42 | Benzodiazepines | active | 2021-07 | hl7 | rx | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1206.43 | LoopDiuretics | active | 2021-07 | hl7 | rx | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1206.44 | Antiepileptics | active | 2021-07 | hl7 | rx | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1206.45 | Antipsychotics | active | 2021-07 | hl7 | rx | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1206.36 | Hemiplegia Symptoms | active | 2021-07 | hl7 | icd | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1206.37 | Leg Weakness Symptoms | active | 2021-07 | hl7 | icd | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1206.38 | Osteopenia Symptoms | active | 2021-07 | hl7 | icd | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1206.39 | Stroke Symptoms | active | 2021-07 | hl7 | icd | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1206.40 | Vestibular Symptoms | active | 2021-07 | hl7 | icd | ||
us.cdc.phinvads | R4 | 2.16.840.1.113883.1.11.19579 | Family Member Value Set | active | 2009-01 | tho | |||
fhir.cdc.opioid-cds-r4 | R4 | fentanyl-type-medications | Fentanyl-type medications | active | 2025-02 | hl7 | |||
hl7.fhir.us.breast-radiology | R4 | FibroAdenomaAbnormalityTypeVS | FibroAdenoma Abnormality Type ValueSet | active | 2022-12 | hl7 | fhir | ||
us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.3382 | Query Priority (IIS) | active | 2010-01 | tho | |||
hl7.fhir.us.vrdr | R4 | vrdr-filing-format-vs | Filing Format ValueSet | active | pher | 2024-10 | hl7 | fhir | |
us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.7769 | Final Treatment Outcome (TB) | active | 2017-12 | sct tho oid | |||
us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.3144 | Treatment Outcome Tetanus (VPD) | active | 2008-01 | sct tho | |||
hl7.fhir.us.davinci-pct | R4 | PCTFinancialTypeVS | PCT Financial Type Value Set | trial-use | fm | 2025-06 | hl7 | fhir | |
fhir.cdc.opioid-cds-r4 | R4 | hospice-finding | Hospice Finding | active | 2023-05 | hl7 | sct | ||
fhir.cdc.opioid-cds-r4 | R4 | pdmp-data-reviewed-finding | PDMP data reviewed finding | active | 2023-05 | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1121.6 | Most/Moderately Effective Contraceptive SNOMED Findings | active | 2024-06 | hl7 | sct | ||
us.cdc.phinvads | R4 | 2.16.840.1.113883.10.14.1.1.13.7 | Placental Conditions (HL7) | active | 2017-01 | sct | |||
hl7.fhir.us.registry-protocols | R4 | FirstCardiacArrestRhythm | First Cardiac Arrest Rhythm | active | cic | 2023-11 | hl7 | fhir | |
us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.3587 | Flu Activity Code | active | 2010-01 | sct oid | |||
us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.3255 | Case Contact Signs and Symptoms (Flu) | active | 2009-01 | sct | |||
us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.7787 | Food Allergy (Listeria) | active | 2018-01 | sct tho oid | |||
us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.3070 | Botulism Food Source Type (FDD) | active | 2008-01 | tho oid | |||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1166.167 | Contraceptive Implant LOINC | active | 2021-10 | hl7 | loinc | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1166.140 | IUD Devices | active | 2022-03 | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1166.130 | Contraceptive Implants RXNORM Medications | active | 2021-10 | hl7 | rx | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1166.131 | Injectable Contraceptive RXNORM Medications | active | 2021-10 | hl7 | rx | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1166.132 | Oral Contraceptive Pills RXNORM Medications | active | 2025-04 | hl7 | rx | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1166.129 | Contraceptive Ring RXNORM Medications | active | 2021-10 | hl7 | rx | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1166.139 | IUD Provision Procedures | active | 2022-03 | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1166.192 | Contraceptive Implant SNOMED Surveillance Procedures | active | 2021-11 | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1166.138 | IUD Surveillance | active | 2021-10 | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1166.85 | Intrauterine Devices RXNORM Medications | active | 2021-10 | hl7 | rx | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1166.205 | Prenatal Care Bundle Visits | active | 2021-11 | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1166.133 | Pregnancy Related Diagnoses | active | 2021-10 | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1166.103 | Female Sterilization HCPCS Devices | active | 2021-10 | hl7 | cms | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1166.105 | Female Sterilization ICD10CM Provision Encounters | active | 2021-10 | hl7 | icd | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1166.109 | Sterilization SNOMED Findings | active | 2024-10 | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1166.134 | Female Sterilization SNOMED Provision Procedures | active | 2024-10 | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1166.142 | Female Sterilization Provision Procedures | active | 2022-03 | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1166.93 | Female Sterilization CPT Provision Procedures | active | 2021-10 | hl7 | cpt | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1166.98 | Female Sterilization LOINC | active | 2021-10 | hl7 | loinc | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1166.99 | Female Sterilization ICD10PCS Provision Procedures | active | 2021-10 | hl7 | cms | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1166.118 | Infecund Not for Contraceptive Reasons CPT Procedures | active | 2024-10 | hl7 | cpt | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1166.119 | Infecund Not for Contraceptive Reasons HCPCS Procedures | active | 2021-10 | hl7 | cms | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1166.97 | Infecund Not for Contraceptive Reasons ICD10CM | active | 2021-10 | hl7 | icd | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1166.125 | Non Live Birth Diagnoses ICD10CM | active | 2021-10 | hl7 | icd | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1166.126 | Non Live Birth Diagnoses SNOMED | active | 2025-04 | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1166.127 | Non Live Birth CPT Procedures | active | 2022-06 | hl7 | cpt | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1166.128 | Non Live Birth ICD10PCS Procedures | active | 2021-10 | hl7 | cms | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1166.136 | Non Live Birth Procedures | active | 2021-10 | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1166.137 | Non Live Birth Diagnoses | active | 2021-10 | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1166.204 | Prenatal Care Bundle CPT | active | 2021-11 | hl7 | cpt | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1166.120 | Prenatal Care Visits CPT | active | 2021-10 | hl7 | cpt | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1166.121 | Prenatal Care Visits HCPCS | active | 2021-10 | hl7 | cms | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1166.122 | Prenatal Care Visits SNOMED | active | 2021-10 | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1166.135 | General Prenatal Care Visits | active | 2022-03 | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1166.111 | Prenatal Care Specific Visits CPT | active | 2021-10 | hl7 | cpt | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1166.112 | Prenatal Care Specific Visits HCPCS | active | 2021-10 | hl7 | cms | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1166.113 | Prenatal Care Specific Visits SNOMED | active | 2021-10 | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1166.114 | Prenatal Care Specific Visits | active | 2022-03 | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1166.110 | Pregnancy Bundle Visits | active | 2021-10 | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1166.168 | Pregnancy Bundle CPT | active | 2021-10 | hl7 | cpt |